CordenPharma Leadership Team
CordenPharma was created in 2006 as a privately held pharmaceutical brand of International Chemical Investors Group (ICIG). With 9 cGMP facilities across Europe and the US, CordenPharma is headed by a Leadership Team which includes CordenPharma Leadership, CordenPharma International Platform Directors, and CordenPharma Facility Managing Directors.
Mr. Ernesto Petroselli joined CordenPharma in 2012 as Managing Director of CordenPharma Latina (IT). In 2013 he assumed the role of President, CordenPharma, while continuing to serve as Interim Managing Director of CordenPharma Latina. Prior to joining CordenPharma, Ernesto gained extensive operations and management experience over 30 years of progressive responsibility working in various positions at Johnson & Johnson Pharma from Operations Manager and VP of Operations in Europe and Asia, to VP, Global Pharmaceutical Network and VP, Global OTC Supply Chain. Other work experience includes Dow-Lepetit Garessio, Dow Chemical-Livorno, and Coca Cola Export Corporation in the Balkan States and North Africa. Ernesto holds a degree in Mechanical Engineering.
Dr. Christian Ewers
Vice President, CordenPharma
Dr. Christian Ewers joined CordenPharma in 2012 as the Managing Director of CordenPharma Switzerland. In June of 2013 he became Chief Operating Officer of CordenPharma International API business with oversight of CordenPharma Colorado, CordenPharma Switzerland, Farchemia and CordenPharma France. In 2014 his role slightly changed to become Vice President, CordenPharma, with oversight over all CordenPharma facilities dealing with Peptides, Carbohydrates, Lipids and Injectables.
Group Controller, CordenPharma
Thorsten Becker joined CordenPharma in March 2013 as Group Controller, CordenPharma. Prior to that, he spent most of his career in the automotive industry, where he held a variety of senior finance positions with Tier 1 suppliers such as TRW and Johnson Controls. This gave him extensive experience in finance and accounting, with a focus on profitability improvement and business redesign. After completing assignments in the UK and the US, he was Finance Director for the European restructuring initiatives. Prior to joining CordenPharma, he had the global finance responsibility for the engineering departments in the interior division of Johnson Controls. Thorsten studied at the University of Applied Sciences Würzburg and at Western Michigan University. He holds a degree in Business Administration and International Business.
Dr. Michael Quirmbach
Vice President, Global Sales & Marketing, CordenPharma International (CPI)
Dr. Michael Quirmbach joined CordenPharma in October 2014 as Vice President, Global Sales & Marketing, CordenPharma International. Prior to joining CordenPharma Michael held positions with increasing responsibility at Siegfried AG, Dr. Reddy's, Solvias AG, Speedel, and Albany Molecular Research (AMRI), where he garnered extensive experience in business development, marketing, and sales in the CDMO arena. Michael studied chemistry at the Technical University of Clausthal (DE) and the University of Salford (UK) before completing his PhD at the the Max Planck Research Group “Asymmetric Catalysis” at the Institute for Organic Catalysis Research in Rostock (DE). Following a postdoctoral fellowship at both the University of Colorado, Boulder (USA) and the University of Pennsylvania (USA), Michael completed his MBA from La Salle University in Philadelphia (USA) in 2005.
Dr. Macniell Esua
Compliance Director, CordenPharma International
Dr. Macniell Esua joined CordenPharma in April 2016 as Compliance Director, CordenPharma International. Macniell brings over 15 years extensive experience in diverse leadership functions in the pharmaceutical industry including quality assurance, quality control, manufacturing, pharmaceutical development and compliance management for a wide range of dosage forms, finished products and Active Pharmaceutical Ingredients. He has worked for number of multinational companies such as Hameln Pharmaceuticals, Ranbaxy Ltd., STADA AG, Solvay Pharmaceuticals and Sun Pharma Ltd. in various positions: laboratory head, quality control head, site quality assurance head and most recently, head of quality central southeast Europe. Macniell is an experienced auditor qualified in accordance with Art.22 d. 75/319 EEC, with extensive knowledge in quality and regulatory compliance in major global markets. Macniell holds a PhD in pharmaceutical sciences from the University of Leipzig, Germany.
CordenPharma International Technology Platform Directors
Dr. Mimoun Ayoub
Director, Global Peptides, Oligonucleotides, Lipids, Carbohydrates & Injectables Platforms, CordenPharma International (CPI)
Dr. Mimoun Ayoub joined CordenPharma in November 2013 following the acquisition of Peptisyntha by ICIG as Director, Global Peptides, Oligonucleotides, Lipids, Carbohydrates & Injectables Platforms, CordenPharma International. With over 20 years of experience in the pharmaceutical industry, Mimoun served as Vice President, Global Business & Strategy of Peptisyntha, as well as a member of the Peptisyntha Executive Team and Solvay Life Sciences Leadership Team prior to joining CordenPharma. He also held various senior and executive positions within global pharmaceutical manufacturing companies including Chief Executive Officer, Senn Chemicals, Head of Manufacturing Operations, Senn Chemicals, and Head of Manufacturing and Chemistry at Genzyme Pharmaceuticals. Mimoun holds a Ph.D. in Organic Chemistry from the French University Pierre & Marie-Curie and is still very well connected to the field of academic research.
Director, Global Highly Potent & Oncology Platform,
Jason Bertola joined CordenPharma in 2016 as Director, Global Highly Potent & Oncology Platform, CordenPharma International. Jason began his career in pharmaceutical process development first with SAPEC (now Cerbios) and then Hoffmann-LaRoche before transitioning into business development and sales. He brings over 24 years of diverse leadership experience in the pharmaceutical industry with extensive expertise in contract development and manufacturing, strategy development and business transactions. Prior to joining CordenPharma, Jason was Vice President of Business Development & Strategy for Dishman. Jason holds a B.S. in Chemistry and an MBA from Fairleigh Dickinson University.
Stephen Houldsworth, PhD
Director, Global Small Molecules & Antibiotics Platforms
Dr. Stephen Houldsworth joined CordenPharma in 2017 as Director, Global Small Molecules & Antibiotics Platforms, CordenPharma International. Prior to joining CordenPharma Stephen held various senior positions in R&D, Manufacturing, Operations, Business Development and Sales in Dalton Pharma Services and most recently Apotex Pharmachem. Stephen has a Ph.D. in organic chemistry from the University of Nottingham (UK) where he conducted research in the group of Prof. G. Pattenden, followed by a postdoctoral stay in the group of V. Snieckus at the University of Waterloo (CA).
CordenPharma Facility Managing Directors
Managing Director, CordenPharma Caponago
Angelo Colombo joined CordenPharma is July 2011 as Managing Director, CordenPharma Caponago (IT). Angelo started his career at Farmitalia Carlo Erba and then went on work in several roles of increasing responsibility at Pharmacia / Pfizer, followed by Pierrel and Shering Plough. With over 20 years of experience working in various facilities with the highest quality and safety standards, Angelo has gained extensive expertise in injectable manufacturing in different pharmaceutical forms. He graduated with a degree in Chemical and Pharmaceutical Technologies at the University Statale of Milan.
Managing Director, CordenPharma Chenôve
Yves Michon joined CordenPharma in January 2011 as Managing Director, CordenPharma Chenôve (FR). Yves brings 30 years of experience in the manufacturing and business of Fine Chemicals and APIs with expertise in Production, Continuous Improvement, Project Management and General Management of CMOs. He holds a Master of Science Degree in Process Control & Engineering from ECAM Graduate School of Engineering in Lyon, France.
Managing Director, President & CEO, CordenPharma Colorado
Brian McCudden joined CordenPharma as Managing Director, CordenPharma Colorado (Boulder, CO, USA) in June 2014. Brian is an API executive with extensive experience developing and implementing strategy and building high performing teams. He has broad experience at establishing and improving operations in development, manufacturing, supply chain, sourcing and procurement in API and finished Drug Product. Brian graduated from the University of Delaware with a degree in Chemical Engineering and has an MBA in Finance from Loyola College. Prior to accepting his current position with CordenPharma Colorado, he served as the Vice President, API Strategy at Hospira. Brian also worked for Roche Colorado Corporation as Director of Manufacturing from 1991 - 2002.
Managing Director, CordenPharma Bergamo
Laura Coppi joined CordenPharma in October 2013 as Managing Director, CordenPharma Bergamo (IT) after more than 20 years of experience in various management positions in the pharmaceutical chemical industry. Laura began her career in Process R&D at Zambon Group in 1988. In 1992 her professional pathway shifted toward business and management as Technical Marketing Manager, EAME Generic Sales Manager and Worldwide Contract Manufacturing Manager at Zambon. In 1998 Laura came to the USA to work for Davos Chemical Corporation as Technical Marketing and Key Account Manager. In 1998, Laura went back to Europe and worked for 9 years at the Spanish private group Esteve as R&D and IP Director (Esteve Quimica) and General Manager (Pensa Pharma in Milan). In 2007, Laura joined Wyeth Pharmaceuticals’ New Product and Process Development division as Sr. Director of API Technical Operations, followed by positions as Managing Director of Archimica Srl and Marketing and Sales Director of F.I.S. As an Organic Chemist of the University of Florence, Specialist in Synthetic Organic Chemistry of the University of Milan and author of several publications and patents, Laura complemented her scientific education with a diploma in Marketing from Bocconi University in Milan and a PDG from Iese in Barcelona.
Managing Director, CordenPharma Latina
Emilio Frongia serves as the Managing Director, CordenPharma Latina (IT), after joining CordenPharma in 2010 as Director of Finance & Logistics. Emilio began his career in the consumer electronics business before moving to the pharmaceutical industry to join Alfa Wassermann in 1996 as Financial Controller and Bristol-Myers Squibb in 2006 as Finance Director. Emilio holds a degree in Economics and a CA certification from the University of Rome.
Patrice Locht joined CordenPharma in 2016 as the Managing Director, CordenPharma Brussels (BE). Patrice started his career with several operational roles of increasing responsibility in diversified industries including catalytic systems (Johnson Matthey), detergents and power cables (Nexans) before moving to the genomics and diagnostic GMP grade components business as a Production Manager. Patrice holds a Master degree in Applied Sciences and an International Executive Master of Business Administration degree from the University of Louvain (Belgium).
Managing Director, CordenPharma Brussels
Dr. Jürg Burger
Managing Director, CordenPharma Switzerland
Dr. Jürg Burger joined CordenPharma in 2013 as the Managing Director, CordenPharma Switzerland (CH), with oversight of facilities in both Liestal, CH and Woburn, MA, USA. Prior to joining CordenPharma, Dr. Burger garnered extensive operations management experience over 27 years in various roles at Lonza AG (CH and Hopkinton, US) including Head of Manufacturing Business Sector Exclusive Synthesis, Head of Manufacturing Operations for Pharmaceuticals (small molecules) and later Microbial Fermentations, and most recently Head Business Unit of Global Microbial Operations, VP of Supply Chain and VP of Head Site Services. Jürg earned a PhD and Master Degree in Chemical Engineering from the Swiss Federal Institute of Technology in Zurich (CH).